Omnicell, Inc. (OMCL) is a Technology stock trading at $39.16 (as of 2026-06-18), with a market capitalization of $2.01B and a trailing P/E of 100.3. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.
Omnicell, together with its subsidiaries, provides automated medication and supply management and adherence-related tools for healthcare facilities, hospitals, pharmacies, and related organizations in the United States and internationally. Its offerings include point-of-care dispensing systems, central pharmacy automation, interface and integration software, and supporting inventory and workflow management capabilities.